X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/24/2869046/0/en/Rhythm-Pharmaceuticals-to-Report-First-Quarter-2024-Financial-Results-on-Tuesday-May-7-2024.html
https://www.globenewswire.com/news-release/2024/04/16/2864080/0/en/Rhythm-Pharmaceuticals-Announces-New-Employment-Inducement-Grants.html
https://www.globenewswire.com/news-release/2024/04/01/2855136/0/en/Rhythm-Pharmaceuticals-Secures-150-Million-in-Convertible-Preferred-Stock-Financing.html
https://www.globenewswire.com/news-release/2024/03/25/2851546/0/en/Rhythm-Pharmaceuticals-Announces-First-Patient-Dosed-in-Phase-1-Trial-Evaluating-RM-718-a-Weekly-MC4R-specific-Agonist.html
https://www.globenewswire.com//news-release/2024/03/11/2844132/0/en/Rhythm-Pharmaceuticals-Announces-New-Employment-Inducement-Grants.html
https://www.globenewswire.com//news-release/2024/03/06/2841761/0/en/Rhythm-Pharmaceuticals-Announces-Participation-at-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/02/22/2833540/0/en/Rhythm-Pharmaceuticals-Announces-Clinical-Development-Plan-of-Setmelanotide-for-Hypothalamic-Obesity-in-Japan.html
https://www.globenewswire.com//news-release/2024/02/22/2833504/0/en/Rhythm-Pharmaceuticals-Reports-Fourth-Quarter-2023-Financial-Results-and-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/08/2826425/0/en/Rhythm-Pharmaceuticals-Announces-New-Employment-Inducement-Grants.html
https://www.globenewswire.com//news-release/2024/02/07/2825140/0/en/Rhythm-Pharmaceuticals-Announces-Positive-Reimbursement-Decision-in-Italy-for-IMCIVREE-setmelanotide-for-the-Treatment-of-Obesity-and-Control-of-Hunger-in-Bardet-Biedl-Syndrome.html
Market Place
Share 
